{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/306968931"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Thus, IKKepsilon may represent an attractive therapeutic target for obesity, insulin resistance, diabetes, and other complications associated with these disorders.Comment inIkappaB kinase epsilon: a potential therapeutic target for obesity (and nonalcoholic fatty liver disease)? [Hepatology. 2010]IKKepsilon: a bridge between obesity and inflammation. [Cell. 2009]PMID: 19737522 [PubMed - indexed fo" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "nih.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/322185294"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/306968931" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/23069991"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/306968931"] } } }
